Literature DB >> 25147010

Thromboangiitis obliterans (Buerger's disease).

Peter F Klein-Weigel1, Jutta G Richter2.   

Abstract

Thromboangiitis obliterans (TAO, Buerger's disease) is an inflammatory vascular disease affecting small and medium sized arteries and veins. It is characterized by segmental thrombotic occlusions by highly mononuclear cellular thrombi. Its occurrence and re-occurrence is closely related to tobacco use. Immunohistological examinations and the detections of various autoantibodies led to the new paradigm of an immunopathogenesis of TAO. Clinically it is characterized by distal ischemia syndromes in young people and high amputation rates. This article summarizes the disease characteristics, clinical features, and diagnostic and therapeutic approaches and focuses on new therapeutic options, i.e. stem cell derived therapies, immunoadsorption, and the endothelin-receptor-blocking agent bosentan.

Entities:  

Keywords:  Buerger`s disease; Thromboangiitis obliterans; bosentan; critical limb ischemia; immunoadsorption; progenitor cell therapy; stem cell therapy; vasculitis

Mesh:

Year:  2014        PMID: 25147010     DOI: 10.1024/0301-1526/a000371

Source DB:  PubMed          Journal:  Vasa        ISSN: 0301-1526            Impact factor:   1.961


  9 in total

1.  Unexpected Inflammation in the Sympathetic Ganglia in Thromboangiitis Obliterans.

Authors:  Mahdi Farzadnia; Hassan Ravari; Mitra Masoudian; Narges Valizadeh; Bahare Fazeli
Journal:  Int J Angiol       Date:  2017-07-27

2.  Severe gangrene at the glans penis requiring penectomy as the first major complication of Buerger's disease.

Authors:  Khanh N Pham; Mitchell H Sokoloff; Charles A Steiger
Journal:  Am J Clin Exp Urol       Date:  2016-01-28

3.  The role of folic acid on the hyperhomocysteinemia in the Buerger's disease (Thromboangiitis Obliterans).

Authors:  Ali Akbar Beigi; Mohammad Ali Hoghoughi; Afrooz Eshaghian; Akbar Hassan Zade; Hassan Masoudpour
Journal:  J Res Med Sci       Date:  2014-11       Impact factor: 1.852

Review 4.  Buerger's disease: providing integrated care.

Authors:  Peter Klein-Weigel; Theresa Sophie Volz; Leonora Zange; Jutta Richter
Journal:  J Multidiscip Healthc       Date:  2016-10-12

Review 5.  Efficacy of bosentan in patients with refractory thromboangiitis obliterans (Buerger disease): A case series and review of the literature.

Authors:  Javier Narváez; Carmen García-Gómez; Lorenzo Álvarez; Pilar Santo; María Aparicio; María Pascual; Mercè López de Recalde; Helena Borrell; Joan M Nolla
Journal:  Medicine (Baltimore)       Date:  2016-11       Impact factor: 1.889

6.  Sequential intravenous allogeneic mesenchymal stromal cells as a potential treatment for thromboangiitis obliterans (Buerger's disease).

Authors:  Jorge D Martin-Rufino; Francisco S Lozano; Alba M Redondo; Eva M Villaron; Raquel Rueda; Rafael Fernandez-Samos; Fermin Sanchez-Guijo
Journal:  Stem Cell Res Ther       Date:  2018-05-30       Impact factor: 6.832

7.  Early Results of Clinical Application of Autologous Whole Bone Marrow Stem Cell Transplantation for Critical Limb Ischemia with Buerger's Disease.

Authors:  Seon-Hee Heo; Yoong-Seok Park; Eun-Suk Kang; Kwang-Bo Park; Young-Soo Do; Kyung-Sun Kang; Dong-Ik Kim
Journal:  Sci Rep       Date:  2016-01-21       Impact factor: 4.379

8.  Effect of revascularization on IL-6 and TNF-α in patients with thromboangiitis obliterans.

Authors:  Shifeng Wu; Xin Sun; Wei Wu; Dazhi Shi; Tao Jiang
Journal:  Exp Ther Med       Date:  2018-02-20       Impact factor: 2.447

9.  Autologous peripheral blood-derived stem cells transplantation for treatment of no-option angiitis-induced critical limb ischemia: 10-year management experience.

Authors:  Gang Fang; Xiaolang Jiang; Yuan Fang; Tianyue Pan; Hao Liu; Bichen Ren; Zheng Wei; Shiyang Gu; Bin Chen; Junhao Jiang; Yun Shi; Daqiao Guo; Peng Liu; Weiguo Fu; Zhihui Dong
Journal:  Stem Cell Res Ther       Date:  2020-10-28       Impact factor: 6.832

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.